03
02
04
2018
01
Shanghai Shengyan Biotechnology Company was established
2021
2020
2019
2022 05 06
2023 Establishment of clinical translational cooperation with a number of tertiary hospitals Recognized as a high-tech enterprise for the first time
Lung cancer-derived extracellular vesicles with multiple
The identification of histologic markers and
immunotherapy were awarded by the National
Health Commission and Zhejiang Province
Ministry of Health and Zhejiang Provincial Key R&D Program
Program Obtained 10 patents for inventions
Exosome Extraction System Completes NMPA
Class I filing
Exosome Extraction System Completes NMPA
Production filing